glp-1 and binge eating disorder Experts express alarm that RAs may trigger or worsen disorders. But is there any role they might play in eating disorder? how can clinicians protect patients from risk? GLP-1RAs and Obesity Associated with

The complexity of neural circuits that control food intake and energy balance in the hypothalamic nuclei explains some of the constraints involved in the prevention and treatment of obesity

A 2026 case report describes a 34-year-old man with obesity and alcohol use disorder whose semaglutide treatment for weight loss was associated with a marked drop in drinking over 10 months, with his AUDIT score falling from 27 to 7 and alcohol use dropping from about 15 drinks per week to half a beer per month

Rotate sites to avoid lipodystrophy

Take Our Short Quiz To See If Youre EligibleGet StartedThe GLP-1 program built for real women and real change.Reach your weight goals with medical treatment and on-demand support from Americas most trusted digital weight clinic.Semaglutide Annual $150/mo | Quarterly $250/mo | Monthly $297/moMechanismGLP-1 agonistAverage Weight Loss15% (68 weeks)Standard Starting Dose0.25 mg weeklyMaximum Dose2.4 mg weeklyMedicationUnlimited

H., Yang, R

A double-blind, placebo-controlled, randomized trial of probiotics for primary prevention of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis